首页> 外文OA文献 >Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis
【2h】

Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis

机译:DL-3-N-丁基苯乙烯酯保护心脏抗缺血性损伤和抗氧化应激的H9C2心肌细胞:线粒体功能和生物发生的累积

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Myocardial infarction (MI) is an acute and fatal condition that threatens human health. Dl-3-n-butylphthalide (NBP) has been used for the treatment of acute ischemic stroke. Mitochondria may play a protective role in MI injury. However, there are few reports on the cardioprotective effect of NBP or the potential mitochondrial mechanism for the NBP-induced protection against cardiac ischemia injury. We investigated the therapeutic effects of NBP in an in vivo MI model and an in vitro oxidative stress model, as well as the potential mitochondrial mechanism. Methods This study comprised two different experiments. The aim of experiment 1 was to determine the protective effects of NBP on MI and the underlying mechanisms in vivo. In part 1, myocardial infarct size was measured by staining with 2,3,5-triphenyltetrazoliumchloride (TTC). Myocardial enzymes and mitochondrial enzymes were assayed. The aim of experiment 2 was to investigate the role of NBP in H2O2-induced myocardial ischemic injury in H9c2 cells and to determine the potential mechanism. In part 2, H9c2 cell viability was evaluated. ROS levels, mitochondrial morphology, and mitochondrial membrane potential of H9c2 cells were measured. ATP levels were evaluated using an assay kit; mitochondrial DNA (mtDNA), the expressions of NRF-1 and TFAM, and mitochondrial biogenesis factors were determined. Results NBP treatment significantly reduced the infarct ratio, as observed by TTC staining, decreased serum myocardial enzymes in MI, and restored heart mitochondrial enzymes (isocitrate dehydrogenase (ICDH), succinate dehydrogenase (SDH), malate dehydrogenase (MDH), and a-ketoglutarate dehydrogenase (a-KGDH) activities after MI. Moreover, in in vitro studies, NBP significantly increased the viability of H9c2 cells in a dose-dependent manner, reduced cell apoptosis, protected mitochondrial functions, elevated the cellular ATP levels, and promoted H2O2-induced mitochondrial biogenesis in H9c2 cardiomyoblasts. Conclusion Collectively, the results from both the in vivo and in vitro experiments suggested that NBP exerted a cardioprotective effect on cardiac ischemic injury via the regulation of mitochondrial function and biogenesis.
机译:摘要背景心肌梗死(MI)是威胁人类健康的急性和致命条件。 DL-3-正丁基苯乙烯(NBP)已被用于治疗急性缺血性卒中。线粒体可能在MI损伤中发挥保护作用。然而,关于NBP的心脏保护作用或NBP诱导保护免受心脏缺血损伤的潜在线粒体机制的报道很少。我们研究了NBP在体内MI模型中的治疗效果和体外氧化应激模型,以及潜在的线粒体机制。方法本研究包括两个不同的实验。实验1的目的是确定NBP对体内MI和潜在机制的保护作用。在第1部分中,通过用2,3,5-三苯基四唑烷(TTC)染色来测量心肌梗塞尺寸。测定心肌酶和线粒体酶。实验2的目的是探讨NBP在H2O2诱导的H9C2细胞中诱导心肌缺血性损伤的作用,并确定潜在机制。在第2部分中,评估H9C2细胞活力。测量了ROS水平,线粒体形态和线粒体膜电位。使用测定套件评估ATP水平;测定线粒体DNA(MTDNA),NRF-1和TFAM的表达,以及线粒体生物发生因子。结果Nbp治疗显着降低了梗塞比,如TTC染色,血清心肌酶的观察到,恢复心脏线粒体酶(异柠檬酸脱氢酶(ICDH),琥珀酸脱氢酶(SDH),苹果酸脱氢酶(MDH)和A-Ketoglutarate MI后的脱氢酶(A-KGDH)活性。此外,在体外研究中,NBP以剂量依赖性方式显着增加了H9C2细胞的活力,降低细胞凋亡,受保护的线粒体功能,升高了细胞ATP水平,并促进了H2O2- H9C2心肌细胞中的诱发线粒体生物发生。结论,体内和体外实验的结果表明,NBP通过调节线粒体功能和生物发生施加了对心脏缺血性损伤的心脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号